NEW YORK (GenomeWeb) – Tauriga Sciences said on Thursday that it completed a $600,000 private placement with unnamed institutional and accredited individual investors.

The proceeds will be directed in part to advance the commercialization of the synthetic biology technology platform of its wholly owned subsidiary, Pilus Energy, for industrial wastewater remediation. The platform, called the Electrogenic Bioreaction system, harnesses genetically enhanced bacteria.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.